Stock Analiz

Stoke Therapeutics, Inc. (STOK) stock forecast and price target

Price $26.68 · data as of November 13, 2026

12-month price target

Average target$46.38
Upside / downside+73.9%
Analysts13
ConsensusStrong buy
Low $35.00Average $46.38High $60.00

Gold marker: average target · white marker: today’s price ($26.68)

Analyst ratings

Strong buy 2Buy 12Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-4.01−3243.2%$35M
Next fiscal year
ends December 31, 2027
$-4.09−1.8%$47M
Next quarter
ends December 31, 2026
$-1.19−22.3%$7M
Quarter after
ends March 31, 2027
$-1.19−50.5%$7M

Consensus of the analysts covering Stoke Therapeutics, updated daily. In the last 30 days 0 estimates were raised and 2 lowered.

Frequently asked questions

What is the Stoke Therapeutics stock price target?

The average 12-month target from 13 analysts is $46.38, 73.9% above the current price of $26.68 Targets range from $35.00 to $60.00.

Is Stoke Therapeutics a buy according to analysts?

The consensus rating is “Strong buy” (2 strong buy, 12 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is Stoke Therapeutics expected to earn?

Analysts expect EPS of $-4.01 for the fiscal year ending December 31, 2026 and $-4.09 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.